Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

This study has been completed.

Study NCT00015652 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: April 26, 2001 Last Updated: February 24, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2005 (Final data collection date for primary outcome measure)